Hye-Yeong Jo
Overview
Explore the profile of Hye-Yeong Jo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeon J, Yu S, Lee S, Kim S, Jo H, Jung I, et al.
Bioinformatics
. 2025 Feb;
41(3).
PMID: 39982404
Motivation: Correctly identifying epitope-binding T-cell receptors (TCRs) is important to both understand their underlying biological mechanism in association to some phenotype and accordingly develop T-cell mediated immunotherapy treatments. Although the...
2.
Song H, Jo H, Kim S, Choi S
BMC Infect Dis
. 2024 Nov;
24(1):1237.
PMID: 39497098
Background: Numerous studies have investigated the molecular properties that contribute to the symptoms of COVID-19, such as the virus's genetic makeup, its replication mechanisms, and how it interacts with host...
3.
Han E, Youn S, Kwon K, Kim S, Jo H, Jung I
Sci Rep
. 2024 Oct;
14(1):24712.
PMID: 39433797
Understanding the immune response to COVID-19 is challenging due to its high variability among individuals. To identify differentially expressed cytokines between the deteriorating and recovering phases, we analyzed the Electronic...
4.
Jeon J, Suk Y, Kim S, Jo H, Kim K, Jung I
BMC Bioinformatics
. 2024 Aug;
25(1):271.
PMID: 39169300
Background: Selecting informative genes or eliminating uninformative ones before any downstream gene expression analysis is a standard task with great impact on the results. A carefully curated gene set significantly...
5.
Choi S, Lee W, Kim S, Jo H, Park H, Kim H, et al.
Vaccine
. 2024 Jul;
42(25):126118.
PMID: 39025696
Among new vaccine technologies contributed to the control of the COVID-19 pandemic, ChAdOx1 nCoV-19, a chimpanzee adenovirus (ChAd)-vector vaccine expressing the SARS-CoV-2 spike protein, could be administered globally owing to...
6.
Jeon K, Kim Y, Kang S, Park U, Kim J, Park N, et al.
Front Immunol
. 2023 Mar;
14:1175767.
PMID: 36969212
[This corrects the article DOI: 10.3389/fimmu.2023.1101808.].
7.
Jeon K, Kim Y, Kang S, Park U, Kim J, Park N, et al.
Front Immunol
. 2023 Feb;
14:1101808.
PMID: 36776879
Introduction: Despite of massive endeavors to characterize inflammation in COVID-19 patients, the core network of inflammatory mediators responsible for severe pneumonia stillremain remains elusive. Methods: Here, we performed quantitative and...
8.
Jo H, Kim S, Ahn D, Lee S, Chang S, Jung S, et al.
BMB Rep
. 2022 Aug;
55(9):465-471.
PMID: 35996834
Understanding and monitoring virus-mediated infections has gained importance since the global outbreak of the coronavirus disease 2019 (COVID-19) pandemic. Studies of high-throughput omics-based immune profiling of COVID-19 patients can help...
9.
Jo H, Seo H, Gil D, Park Y, Han H, Han H, et al.
Front Genet
. 2022 Feb;
12:658862.
PMID: 35173760
Macrophages exhibit high plasticity to achieve their roles in maintaining tissue homeostasis, innate immunity, tissue repair and regeneration. Therefore, macrophages are being evaluated for cell-based therapeutics against inflammatory disorders and...
10.
Kim J, Jo H, Ha H, Kim Y
Stem Cell Res
. 2021 Mar;
53:102270.
PMID: 33714852
The Korea National Stem Cell Bank has been banking pluripotent stem cell (PSC) lines since 2012. Quality-controlled and ethically sourced cell lines were developed for distribution. Currently (as of 2020),...